8-K: Catheter Precision Becomes Flyte Aviation, Implements Reverse Stock Split

Catheter Precision, Inc. announced its name change to Flyte Aviation, Inc. and a 1-for-10 reverse stock split, effective October 5, 2026, alongside shareholder approvals for equity plan amendments and option repricing.

Summary

• Catheter Precision, Inc. has officially changed its name to Flyte Aviation, Inc., effective October 5, 2026.
• A 1-for-10 reverse stock split will also take effect on October 5, 2026, reducing the number of outstanding shares from approximately 21 million to 2.1 million.
• Shareholders approved an amendment to the 2023 Equity Incentive Plan, increasing the reserved shares by 5 million.
• A one-time repricing of outstanding stock options was approved, adjusting the exercise price to the Fair Market Value of $0.152 per share as of September 30, 2026.
• The company's common stock is expected to trade under the new ticker symbol VJET on the NYSE American following the split and name change.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative development due to the significant reverse stock split and name change, which often precede or accompany financial distress, despite the approval of equity incentive plans and option repricing.

Positives

• Shareholder approval for increasing the equity incentive plan by 5 million shares, potentially aiding future employee retention and motivation.
• Approval of a one-time stock option repricing to Fair Market Value, which could improve morale for option holders whose options were underwater.
• The company's Board of Directors and stockholders approved the necessary amendments to facilitate the name change and reverse stock split.

Negatives

• The implementation of a reverse stock split, especially a 1-for-10 ratio, is often a sign of a company struggling to maintain its stock price above minimum exchange listing requirements.
• The name change to 'Flyte Aviation, Inc.' suggests a significant pivot in business strategy, the details of which are not elaborated upon in this filing, potentially indicating a departure from its previous focus.
• The repricing of stock options to $0.152 per share, while a positive for option holders, reflects a very low current market valuation for the company's stock.

Risks

• The reverse stock split may not be sufficient to maintain compliance with NYSE American listing standards if the stock price does not recover.
• The strategic shift implied by the name change to 'Flyte Aviation' carries inherent risks associated with entering a new industry or market.
• The low exercise price of repriced options ($0.152) indicates a significant decline in the stock's historical value, posing a risk to shareholder confidence.

Future Outlook

The filing does not contain specific forward-looking financial guidance. However, the reverse stock split and name change suggest a significant strategic shift, the success of which will determine future performance.

Management Comments

• The Company's Board of Directors had previously approved the Plan Amendment, subject to stockholder approval.
• The Repricing applies to options held by the Company's named executive officers and non-employee directors on the same terms as options held by the Company's other employees and consultants.
• Stockholders holding their shares in brokerage accounts or in street name are not required to take any action in connection with the Name Change or the Reverse Stock Split and should direct any questions to their broker, bank or other nominee.

Industry Context

StockSavvy.ai notes that reverse stock splits and name changes are often employed by companies facing significant financial challenges or seeking to pivot their business model. The move to 'Flyte Aviation' suggests a potential diversification or complete change in operational focus, which carries substantial execution risk.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential dilution from increased equity incentive shares; impact of reverse stock split on perception and liquidity; potential long-term impact from strategic shift to aviation.
• Employees: Potential positive impact from repriced options and increased equity incentives, but also uncertainty related to the name change and potential business pivot.
• Option Holders: Benefit from repricing of underwater options to current Fair Market Value.

Next Steps

• The Common Stock is expected to begin trading on the NYSE American under the new name 'Flyte Aviation, Inc.' and new trading symbol 'VJET' on a split-adjusted basis at the opening of trading on October 5, 2026.
• Stockholders of record with questions regarding the Reverse Stock Split or fractional share payments should contact Equiniti.
• The company will continue to incorporate future filings made with the SEC into its existing registration statements.

Key Dates

Recommendation

The combination of a reverse stock split and a name change to a seemingly unrelated industry ('Flyte Aviation') suggests potential underlying financial distress or a significant, unproven strategic pivot. While shareholder approvals for equity plans and option repricing are noted, these do not outweigh the cautionary signals from the reverse split and name change. A 'hold' recommendation reflects the uncertainty and the need for further information on the company's new strategic direction and financial health.

Keywords

Reverse Stock Split, Name Change, Equity Incentive Plan, Stock Options, NYSE American, Flyte Aviation, Catheter Precision, Charter Amendment